OSDPredict™ uses artificial intelligence and machine learning to help sponsors proactively identify and address formulation challenges early—before they can disrupt downstream development.
Artificial intelligence and machine learning (AI/ML) are transforming how drug developers operate—reducing trial-and-error experimentation and conserving active pharmaceutical ingredients (APIs).
OSDPredict™ is a digital toolbox powered by AI and ML that identifies drug formulation challenges early in the development process, before they can become costly downstream setbacks.
OSDPredict™ delivers data-driven foresight into first-in-human dosing, packaging selection, and scale-up planning—helping sponsors develop and deliver innovative therapies to patients faster.
This fact sheet provides an in-depth overview of our innovative digital toolbox, including:
Learn more about OSDPredict™ by downloading our fact sheet.